Ignite Creation Date:
2024-05-06 @ 1:25 AM
Last Modification Date:
2024-10-26 @ 11:03 AM
Study NCT ID:
NCT01800630
Status:
COMPLETED
Last Update Posted:
2019-07-08
First Post:
2013-02-23
Brief Title:
Phase1 Study of Gemcitabine HCl Oral FormulationD07001-F4 in Patients With Advanced Solid Malignancies and Malignant Lymphomas
Sponsor:
InnoPharmax Inc
Organization:
InnoPharmax Inc
Organization Data
Organization:
InnoPharmax Inc
Class:
INDUSTRY
Study ID:
HR-12-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
InnoPharmax Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None